2013 Q3 Global Life Sciences Website Benchmark: Some well known names improving

An organisation’s website is now the vital centre of its communications and particularly so for companies involved in the complex life science sector, so it’s good to see some well-known pharmaceutical names are improving their websites.
By: Sitemorse Ltd
 
LONDON - Sept. 24, 2013 - PRLog -- Our Q3 2013 Global Life Science Index finds the most efficient sites in the sector are those of Idenix Pharmaceuticals of Cambridge, Massachusetts in the USA, Prostrakan, UK subsidiary of Japan’s Kyowa Kirin pharmaceutical company, and Wockhardt, an Indian multinational with a multi-ethnic workforce of 8600 associates from 21 different nationalities globally.

Ensuring stakeholders can get the information they need and at the same time keeping the highest standards and exceeding compliance has to be the target for anyone taking the web seriously, so to score eight or above in the Sitemorse website Index rating really demonstrates that a company is leading the field.

Top place goes to Idenix Pharmaceuticals, Inc. which is engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Headquartered in Cambridge, Massachusetts USA, Its clinical development operations and drug discovery operations are conducted in the USA and the company’s European laboratories in Montpellier, France. We scored the Idenix site 8.2/10 overall, and it rises one place in the table since our Q2 Index.

Just behind Idenix in second place this time with a score of 7.9 in our automated testing is the site of ProStrakan Group PLC, which is owned by Kyowa Hakko Kirin Co., Ltd (KHK) of Japan and is one of Europe’s fastest growing specialty pharmaceutical companies.

Third-placed Wockhardt is India’s leading research-based global healthcare enterprise, working  in the fields of Pharmaceuticals, Biotechnology and a owner of a chain of advanced hospitals.  It boasts three research centres and 12 manufacturing plants, with businesses including the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

Wockhardt rises a whopping 49 places in the survey and receives an overall score of 7.8/10.The company’s UK site has risen 22 places this quarter to 34th overall.

Retaining fourth and fifth place in this quarter’s Index are the sites of Renovo and Mylan UK.

Sitemorse has been benchmarking and rating the websites of businesses and organisations in a number of sectors for a decade. The full results from this and other recent surveys can be seen on our website. Testing is undertaken using automated software that reads the first 125 pages of each site to generate a ranked table.

·         The best-known names in global life sciences do not always have the best websites, in our experience. But this time we have noted improvements in the websites of a number of the largest companies. Johnson and Johnson has risen 117 places in the Index to 134th, while Roche rises 98 places to 65th overall. Lilly UK is up one to 18th place, Pfizer UK rises four to 27th, and AstraZeneca goes up 25 places to 30th overall.

Top risers this time are MediGene (+118 to 42nd), Laboratoires Thea (+131to 58th) and ImmunoGen (+164to 16th)

·         Fast-loading web pages are important, so readers of our Index might be interested to see the average response time we recorded when testing each site. A response time above 0.75 seconds can have a negative effect on user experience.  Mylan UK, Servier UK, Otsuka Pharmaceuticals Europe,  ProStrakan Group PLC and Sanofi UK are in the top five here, with average response times in Mylan’s case just 0.01 seconds on average for a tested page to load.

·         Accessibility, backed by law, remains a key criterion for any website. Highest scorer in this sector is Canadian R&D company Apotex, which was rated as 8/10 in our tests

About the Index

The quarterly Index Website Review, powered by the Sitemorse software platform, is an important independent benchmark that clearly shows how websites are performing, meeting compliance levels and satisfying their users. It’s also a key indicator for website managers who, while always wanting to be at the top of their game, could be hampered by poor-performing suppliers, non-compliant legacy content or content management systems that often fail to spot errors affecting user experience.

Sitemorse services such as Governisation and the Web Management Toolkit immediately find the issues that affect web users the most on any website, help demonstrate real improvement and ensure you have control and confidence in your web presence.

They will help you minimise unnecessary risk, issues covering everything from compliance with web standards to helping you deal with malware, protect your brand across even a large web presence, and enhance search engine optimisation to help more potential customers find you. They can help spotlight content that may need updating, issues with staff training and support, and focus supplier management. We offer a confidential internal 'company wide' website testing and benchmarking service - allowing you to review the position of all the sites in your organisation. Contact us to request further details and / or an example.

More information

More information about our surveys and what they test can be found on our website http://www.sitemorse.com/survey/

For further Information: Geoff Paddock, Head of Communications on +44 207 183 5588gpaddock@Sitemorse.com
End
Source:Sitemorse Ltd
Email:***@sitemorse.com Email Verified
Tags:Pharmaceutical Websites, Life Sciences, Life Science Websites
Industry:Biotech, Internet
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Governisation PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share